Healthcare provider profile · identity verified

John William Brinker, D.O.

Family Practice · STROUDSBURG, PA · NPI 1659320604

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	293	70
Atorvastatin Calcium	Atorvastatin Calcium	232	67
Amlodipine Besylate	Amlodipine Besylate	229	62
Meloxicam	Meloxicam	193	44
Pantoprazole Sodium	Pantoprazole Sodium	154	42
Gabapentin	Gabapentin	143	43
Lisinopril	Lisinopril	133	38
Metformin Hcl	Metformin Hcl	132	38
Alprazolam	Alprazolam	118	31
Simvastatin	Simvastatin	116	34
Omeprazole	Omeprazole	115	36
Metoprolol Succinate	Metoprolol Succinate	114	37
Losartan Potassium	Losartan Potassium	107	29
Lorazepam	Lorazepam	99	31
Furosemide	Furosemide	97	24
Hydrochlorothiazide	Hydrochlorothiazide	90	25
Rosuvastatin Calcium	Rosuvastatin Calcium	88	26
Pravastatin Sodium	Pravastatin Sodium	85	24
Escitalopram Oxalate	Escitalopram Oxalate	83	20
Atenolol	Atenolol	75	22
Metoprolol Tartrate	Metoprolol Tartrate	71	15
Zolpidem Tartrate	Zolpidem Tartrate	67	22
Ropinirole Hcl	Ropinirole Hcl	66	suppressed
Jardiance	Empagliflozin	64	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	64	11
Tamsulosin Hcl	Tamsulosin Hcl	64	18
Clopidogrel	Clopidogrel Bisulfate	60	14
Oxycodone Hcl	Oxycodone Hcl	53	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	51	suppressed
Sertraline Hcl	Sertraline Hcl	50	17
Fluticasone Propionate	Fluticasone Propionate	48	17
Buspirone Hcl	Buspirone Hcl	46	suppressed
Azelastine Hcl	Azelastine Hcl	44	15
Montelukast Sodium	Montelukast Sodium	42	11
Rybelsus	Semaglutide	42	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	41	suppressed
Methylprednisolone	Methylprednisolone	41	36
Temazepam	Temazepam	41	suppressed
Donepezil Hcl	Donepezil Hcl	39	suppressed
Primidone	Primidone	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	12
Fenofibrate	Fenofibrate Nanocrystallized	37	suppressed
Lovastatin	Lovastatin	37	suppressed
Valsartan	Valsartan	35	15
Warfarin Sodium	Warfarin Sodium	35	suppressed
Eliquis	Apixaban	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Trazodone Hcl	Trazodone Hcl	31	11
Allopurinol	Allopurinol	29	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	20
Tramadol Hcl	Tramadol Hcl	29	12
Albuterol Sulfate Hfa	Albuterol Sulfate	28	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Celecoxib	Celecoxib	28	suppressed
Famotidine	Famotidine	28	12
Finasteride	Finasteride	28	11
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	suppressed
Prednisone	Prednisone	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Glipizide Er	Glipizide	26	suppressed
Potassium Chloride	Potassium Chloride	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Clonazepam	Clonazepam	24	suppressed
Divalproex Sodium	Divalproex Sodium	24	suppressed
Irbesartan	Irbesartan	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Risperidone	Risperidone	21	suppressed
Carvedilol	Carvedilol	20	suppressed
Eszopiclone	Eszopiclone	20	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	12
Metformin Hcl Er	Metformin Hcl	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Azithromycin	Azithromycin	16	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	14
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	11
Nystatin	Nystatin	16	suppressed
Risedronate Sodium	Risedronate Sodium	16	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	15	suppressed
Cephalexin	Cephalexin	15	14
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Ozempic	Semaglutide	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	12
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Cefdinir	Cefdinir	13	12
Levetiracetam	Levetiracetam	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Diazepam	Diazepam	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Invokana	Canagliflozin	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Ropinirole Er	Ropinirole Hcl	11	suppressed
Spironolactone	Spironolactone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error